在日本妇女的非侵入性产前检测中检测到的母体拷贝数变化
Kaku Masuda1, Hiroyuki Mishima2,3, Koh-Ichiro Yoshiura2,3
1Department of Obstetrics and Gynecology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. kmasuda0930@gmail.com.
Journal of human genetics
|January 13, 2026
概括
非侵入性产前检测 (NIPT) 可以检测日本孕妇的母体拷贝数变化 (CNVs) ≥0.8 Mbp. 这些CNV通常是良性的,不会影响生育能力或早期流产风险.
科学领域:
- 基因组学就是基因组学.
- 产前诊断 在产前诊断
- 人类遗传学 人类遗传学
背景情况:
- 非侵入性产前检测 (NIPT) 分析来自母亲血液的无细胞胎儿DNA,以检测染色体异常.
- 尼普特的全基因组测序能力还允许检测母体基因组信息,包括拷贝数变异 (CNV).
- 现有的关于母体CNV的大规模研究是有限的,特别是在日本人群中.
研究的目的:
- 在日本孕妇中进行第一个多中心,大规模的母性CNV队列研究.
- 建立可靠的检测门,并评估通过NIPT识别的母体CNV的临床意义.
- 评估日本队列中母性CNV的流行率和特征.
主要方法:
- 对46,082名接受NIPT的日本孕妇进行分析.
- 使用数组比较基因组杂交方法验证已识别的母体CNV.
- 接收器操作特征 (ROC) 曲线分析以确定最佳的CNV检测值.
- 检测到的CNV与公共基因组数据库 (ToMMo,gnomAD) 的比较.
主要成果:
- 确定了0.8Mbp的最低值,用于100%的特异性检测母体的CNV.
- 在6.3% (2907/46,082) 的参与者中检测到母亲的CNV.
- 最常见的CNV是在chr8: 3,842,478-6,092,478 (频率为2.67%) 的重复.
- 所有检测到的CNV都与公共数据库,特别是ToMMo,具有很高的一致性.
- 还确定了几种罕见的母体CNV.
结论:
- 在日本孕妇中,NIPT可靠地检测到母亲的CNV≥0.8Mbp.
- 已识别的母体CNV主要是良性基因组变异.
- 这些CNV不太可能与对生育能力或早期流产的不良影响有关.
相关概念视频
Comparing Copy Number Variations and SNPs
18.6K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.6K
Single Nucleotide Polymorphisms-SNPs
17.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.9K


